Ischemic stroke is the leading cause of death and disability worldwide. Nevertheless, there
still lacks the effective therapies for ischemic stroke. Microglia are resident macrophages of …

Stroke is one of the most common causes of death worldwide. The subsequent development
of neuroinflammation and brain edema dramatically increases the risks associated with …

Stroke is the leading cause of disability and death worldwide, with ischemic stroke occurring
in~ 5% of the global population every year. Recently, many studies have been conducted on …

It is widely known that ischemic stroke is the prominent cause of death and disability. To
date, neuroinflammation following ischemic stroke represents a complex event, which is an …

Ischemic stroke is the most common type of stroke, which is the main cause of death and
disability on a global scale. As the primary immune cells in the brain that are crucial for …

Microglia, as the intrinsic immune cells in the brain, are activated following ischemic stroke.
Activated microglia participate in the pathological processes after stroke through …

Stroke ranks second as a leading cause of death and permanent disability globally.
Microglia, innate immune cells in the brain, respond rapidly to ischemic injury, triggering a …

Ischemic stroke is one of the leading causes of mortality and disability worldwide. However,
there is a current lack of effective therapies available. As the resident macrophages of the …

Traditionally, microglia/macrophage activation is thought to be detrimental in ischemic
stroke. However, there is increasing evidence that microglia/macrophage activation is …

Stroke is a leading cause of morbidity and mortality worldwide, and consists of two types,
ischemic and hemorrhagic. Currently, there is no effective treatment to increase the survival …